IndiaTickerLatest filing: Asston Pharmaceuticals Ltd - 544445 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
ObservedCompany dossier
Asston Pharmaceuticals
BSE:APL · ISIN INE0SJX01015
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Asston Pharmaceuticals
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest ownership: promoter group 50.66% and public 49.34% as of 31 Mar 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Asston Pharmaceuticals Ltd - 544445 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
BSE · exchange filing
Observed
Source filing Asston Pharmaceuticals Ltd - 544445 - Announcement under Regulation 30 (LODR)-Newspaper Publication
BSE · exchange filing
Observed
Source filing Asston Pharmaceuticals Ltd - 544445 - Notice Of Second Extraordinary General Meeting For F.Y. 2026-27 Scheduled To Be Held On 31St July, 2026 At 12:30 PM
BSE · exchange filing
Observed
Source filing Asston Pharmaceuticals Ltd - 544445 - Announcement Regarding Extraordinary General Meeting Of The Company.
BSE · exchange filing
Reported financials
Full financials →Awaiting structured filing
No reconciled records in this module yet
Structured financial facts have not been reconciled.
Ownership
Full shareholding →31 Mar 2026
- Promoter group
- 50.66%
- Public
- 49.34%
- Employee trust
- N/A
Observed BSE shareholding XBRL